Previous close | 31.65 |
Open | 31.65 |
Bid | 46.35 |
Ask | 49.70 |
Strike | 210.00 |
Expiry date | 2024-09-20 |
Day's range | 31.65 - 31.65 |
Contract range | N/A |
Volume | |
Open interest | 21 |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.